Literature DB >> 3689063

Nosocomial fungemia in a large community teaching hospital.

R L Harvey1, J P Myers.   

Abstract

This report reviews 48 episodes of hospital-acquired fungemia that occurred over a four-year period at a large community teaching hospital. The incidence of hospital-acquired fungemia increased eightfold during the study period. Candida albicans (58%), Candida tropicalis (25%), and Candida parapsilosis (15%) were the most common fungal pathogens isolated from blood cultures. Twenty-one patients (44%) had concomitant bacteremia. Intravascular catheters (100%), antibiotic administration (98%), urinary catheters (81%), surgical procedures (65%), parenteral alimentation (60%), and corticosteroid administration (54%) were the most common predisposing factors. The overall mortality rate was 75%. Hospitalization on the medical service, age greater than 60 years, and hospital stay less than 100 days were associated with a significantly increased mortality rate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689063

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  22 in total

1.  Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India.

Authors:  A Chakrabarti; K Singh; A Narang; S Singhi; R Batra; K L Rao; P Ray; S Gopalan; S Das; V Gupta; A K Gupta; S M Bose; M M McNeil
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients.

Authors:  R K Pelz; C W Hendrix; S M Swoboda; M Diener-West; W G Merz; J Hammond; P A Lipsett
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

3.  Value of the Cand-Tec Candida antigen assay in the diagnosis and therapy of systemic candidiasis in high-risk patients.

Authors:  I Cabezudo; M Pfaller; T Gerarden; F Koontz; R Wenzel; R Gingrich; K Heckman; C P Burns
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

4.  Epidemiology of nosocomial fungal infections.

Authors:  S K Fridkin; W R Jarvis
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

5.  Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.

Authors:  M A Pfaller; Q Vu; M Lancaster; A Espinel-Ingroff; A Fothergill; C Grant; M R McGinnis; L Pasarell; M G Rinaldi; L Steele-Moore
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

6.  Pulmonary fungal infections in patients with hematological malignancies--diagnostic approaches.

Authors:  M von Eiff; M Zühlsdorf; N Roos; M Hesse; R Schulten; J van de Loo
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

7.  Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.

Authors:  A S Bayer; M D Witt; E Kim; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

8.  Endothelial cell contraction increases Candida adherence to exposed extracellular matrix.

Authors:  S A Klotz; R D Maca
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

9.  Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.

Authors:  M A Pfaller; M Bale; B Buschelman; M Lancaster; A Espinel-Ingroff; J H Rex; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

Review 10.  Impact of the changing epidemiology of fungal infections in the 1990s.

Authors:  M Pfaller; R Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.